CASP2 and neuroblastoma: Together, these data identify altered expression levels of several Wnt-associated genes and suggest a fine-tuning of Wnt signaling components in Th-MYCN/Casp2−/− tumors that may determine neural crest cell (NCC) specification to influence neuroblastoma onset.